7 research outputs found
Clinical outcome of ER-negative tumor cases (within 0 to 5 years follow up) in relation with morphological and clinicopathological data.
<p>Clinical outcome of ER-negative tumor cases (within 0 to 5 years follow up) in relation with morphological and clinicopathological data.</p
C-erbB2 overexpression shows strong positivity (3+) on the cell membrane by immunohistochemistry (×200 magnification).
<p>C-erbB2 overexpression shows strong positivity (3+) on the cell membrane by immunohistochemistry (×200 magnification).</p
Correlation between tumor grade and menopausal status, tumor size, lymph node metastases in MIB-1 triple negative breast cancers.
<p>Correlation is significant at the 0.05 level (2-sided).</p
Significant correlation between tumor staging and tumor size, tumor grade, lymph node metastases in ER-negative tumor.
<p>Correlation is significant at the 0.05 level (2-sided).</p
Significant correlation between axillary lymph node metastases and tumor margin in ER-negative tumor.
<p>Correlation is significant at the 0.05 level (2-sided).</p
Immunohistochemical stain for ER in invasive breast carcinoma showing strong nuclear positivity (×200 magnification).
<p>Immunohistochemical stain for ER in invasive breast carcinoma showing strong nuclear positivity (×200 magnification).</p
Correlation between MIB-1 status with clinicopathological findings and morphologic features.
<p>Correlation is significant at the 0.05 level (2-sided).</p